{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:29:54Z","timestamp":1787941794386,"version":"build-2784847793"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1093\/jac\/dki032","type":"journal-article","created":{"date-parts":[[2005,2,19]],"date-time":"2005-02-19T01:23:43Z","timestamp":1108776223000},"page":"574-578","source":"Crossref","is-referenced-by-count":30,"title":["Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis"],"prefix":"10.1093","volume":"55","author":[{"given":"Jennifer M.","family":"Streit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith N.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Alder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,4]]},"reference":[{"key":"key\n\t\t\t\t20171010182551_R1","doi-asserted-by":"crossref","unstructured":"Jones, R. N. & Barry, A. L. (1987). Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility test recommendations. Antimicrobial Agents and Chemotherapy31, 625\u20139.","DOI":"10.1128\/AAC.31.4.625"},{"key":"key\n\t\t\t\t20171010182551_R2","doi-asserted-by":"crossref","unstructured":"Thorne, G. M. & Alder, J. (2002). Daptomycin: A novel lipopeptide antibiotic. Clinical Microbiology Newsletter24, 33\u20139.","DOI":"10.1016\/S0196-4399(02)80007-1"},{"key":"key\n\t\t\t\t20171010182551_R3","doi-asserted-by":"crossref","unstructured":"Silverman, J. A., Perimutter, N. G. & Shapiro, H. M. (2003). Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy47, 2538\u201344.","DOI":"10.1128\/AAC.47.8.2538-2544.2003"},{"key":"key\n\t\t\t\t20171010182551_R4","doi-asserted-by":"crossref","unstructured":"Laganas, V., Alder, J. S. & Werman, J. A. (2003). In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis. Antimicrobial Agents and Chemotherapy47, 2682\u20134.","DOI":"10.1128\/AAC.47.8.2682-2684.2003"},{"key":"key\n\t\t\t\t20171010182551_R5","doi-asserted-by":"crossref","unstructured":"Fuchs, P. C., Barry, A. L. & Brown, S. D. (2000). Daptomycin susceptibility tests: Interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagnostic Microbiology and Infectious Disease38, 51\u20138.","DOI":"10.1016\/S0732-8893(00)00164-4"},{"key":"key\n\t\t\t\t20171010182551_R6","doi-asserted-by":"crossref","unstructured":"Fuchs, P. C., Barry, A. L. & Brown, S. D. (2001). Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media. Journal of Antimicrobial Chemotherapy48, 557\u201361.","DOI":"10.1093\/jac\/48.4.557"},{"key":"key\n\t\t\t\t20171010182551_R7","doi-asserted-by":"crossref","unstructured":"Critchley, I. A., Blosser-Middleton, R. S., Jones, M. E. et al. (2003). Baseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000\u20132001. Antimicrobial Agents and Chemotherapy47, 1689\u201393.","DOI":"10.1128\/AAC.47.5.1689-1693.2003"},{"key":"key\n\t\t\t\t20171010182551_R8","doi-asserted-by":"crossref","unstructured":"King, A. & Phillips, I. (2001). The in vitro activity of daptomycin, vancomycin, and penicillin against 564 Gram-positive aerobic clinical isolates. Journal of Antimicrobial Chemotherapy48, 219\u201323.","DOI":"10.1093\/jac\/48.2.219"},{"key":"key\n\t\t\t\t20171010182551_R9","unstructured":"National Committee for Clinical Laboratory Standards. (2005). Performance Standards for Antimicrobial Susceptibility Testing, Fifteenth Information Supplement M100-S15. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010182551_R10","unstructured":"National Committee for Clinical Laboratory Standards. (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A6. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010182551_R11","unstructured":"National Committee for Clinical Laboratory Standards. (2003). Performance Standards for Antimicrobial Disk Susceptibility Tests\u2014Eighth Edition: Approved Standard M2-A8. NCCLS, Wayne, PA, USA."},{"key":"key\n\t\t\t\t20171010182551_R12","doi-asserted-by":"crossref","unstructured":"Diekema, D. J., Beach, M. L., Pfaller, M. A. et al. (2001). Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clinical Microbiology and Infection7, 152\u20137.","DOI":"10.1046\/j.1198-743x.2001.00230.x"},{"key":"key\n\t\t\t\t20171010182551_R13","doi-asserted-by":"crossref","unstructured":"Arbeit, R. D., Maki, D., Tally, F. P. et al. (2004). The safety and efficacy of daptomycin for the treatment of complicated skin and skin structure infections. Clinical Infectious Disease38, 1673\u201381.","DOI":"10.1086\/420818"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/4\/574\/2399509\/dki032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:53:57Z","timestamp":1507683237000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/4\/574\/801115\/Daptomycin-tested-against-915-bloodstream-isolates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4]]},"published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki032","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,4]]},"published":{"date-parts":[[2005,4,1]]}}}